VeriMommyricetin sesquicaprylate est-il sûr pendant la grossesse ?
No harmonised CLP classification, no SCCS/CIR reproductive safety assessment located for this ingredient, and the parent compound myricetin lacks consistent evidence of human teratogenicity; published literature on myricetin mainly reports biological activity and some protective/reparative effects in animal models rather than reproductive hazard. Topical esters are expected to have low but measurable dermal absorption; therefore exposure during pregnancy is low but not nil. (Sources: PubMed review on myricetin; cosmetic ingredient databases listing myricetin sesquicaprylate; EWG myricetin page).
Related ingredients
Frequently asked questions
- myricetin sesquicaprylate est-il sûr pendant la grossesse ?
- No harmonised CLP classification, no SCCS/CIR reproductive safety assessment located for this ingredient, and the parent compound myricetin lacks consistent evidence of human teratogenicity; published literature on myricetin mainly reports biological activity and some protective/reparative effects in animal models rather than reproductive hazard. Topical esters are expected to have low but measurable dermal absorption; therefore exposure during pregnancy is low but not nil. (Sources: PubMed review on myricetin; cosmetic ingredient databases listing myricetin sesquicaprylate; EWG myricetin page).
- myricetin sesquicaprylate est-il sûr pendant l'allaitement ?
- No data found showing reproductive or lactation-specific toxicity or harmonised classification for myricetin sesquicaprylate. Dermal use in nursing parent is expected to give low but measurable exposure; transfer into breastmilk after topical use is unlikely but not studied for this ester specifically.
- myricetin sesquicaprylate est-il sûr pour la peau de bébé ?
- No infant-specific safety studies located for the sesquicaprylate ester. Because infants (0–3 yr) have higher skin permeability and surface‑area‑to‑weight ratio, exposure score is increased by +1 compared with adults (adult e=1 → infant e=2). No evidence was found to indicate the ingredient is a developmental toxin or endocrine disruptor at expected topical exposures.
- Comment VeriMom évalue-t-il myricetin sesquicaprylate ?
- VeriMom évalue myricetin sesquicaprylate à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à myricetin sesquicaprylate pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à myricetin sesquicaprylate basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.